HIV Infection Clinical Trial
Official title:
Impact on New HIV/HCV Infection Diagnoses and Costs of Two HIV/HCV Testing Programs "Education and Support Only" Versus "Education and Support Plus a Resourced External Program (DRIVE 03)"
Objectives: A targeted HIV testing strategy (TTS) through an HIV risk of exposure and
indicator conditions (RE&IC) questionnaire resulted in same rate of new HIV infection
diagnosis (NHID), coverage and even reduced costs compared with a universal non targeted (Non
TSS) HIV testing strategy in a prior study (DRIVE 01). To compare number of New HIV/HCV
Infection Diagnoses (NHID HIV/HCV) and costs two HIV/HCV testing programs in the Primary
Health Care: an educational and support only initiative to enhance HIV /HCV testing (EDSUP)
or EDSUP plus a resourced external program (DRIVE 03).
Methodology: Prospective, randomized 1:1, clustered, crossover study, in one Health Care Area
of Madrid, Spain, comparing the implementation of two HIV testing programs, EDSUP only vs.
EDSUP plus DRIVE 03 program in 4 Primary Care Centers (PCC´s). People randomized to EDSUP
plus DRIVE 03 program, non HIV infected, between 18-65 years, attending to any of the 4
PCC´s, not previously included in the study will be offered to participate. HIV testing
program will be evaluated by measuring absolute number of new diagnosed infections (NDI)
HIV/HCV and costs. Other outcomes considered will be people assigned and offered to
participate, number of HIV tests performed, coverage (HIV /HCV tests/assigned population
ratio), and rate of NDI HIV/HCV per ‰ tests performed. Six months prior to randomization main
outcome variables will be recorded in the 4 PPC´s. Before randomization, EDSUP will be
equally implemented in the 4 PCC´s. After randomization, first six months, DRIVE 03 program
will be implemented in 2 PCC´s and in the other 2 observation of interest variables will be
conducted. After first 6 month study period, PCC´s will be crossover to the opposite arm of
randomization. DRIVE 03 program will offer rapid HIV tests, and testing staff to conduct all
study procedures. For NDI HIV/HCV, molecular epidemiology, delayed diagnosis, retention in
care, HIV/HCV treatment and control/eradication will be also monitored.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT02135419 -
Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Lesions
|
Phase 3 | |
| Active, not recruiting |
NCT02663856 -
My Smart Age With HIV: Smartphone Self-assessment of Frailty
|
||
| Completed |
NCT02846402 -
Impact of HIV Self-testing Among Female Sex Workers in Kampala, Uganda
|
N/A | |
| Completed |
NCT02921516 -
Growing Up: Intervening With HIV-Positive Adolescents in Resource-Poor Settings
|
N/A | |
| Completed |
NCT02663869 -
Aging With HIV at Younger vs Older Age: a Diverse Population With Distinct Comorbidity Profiles
|
||
| Completed |
NCT02659306 -
Metformin Immunotherapy in HIV Infection
|
Phase 1 | |
| Terminated |
NCT02743598 -
Liraglutide for HIV-associated Neurocognitive Disorder
|
Phase 4 | |
| Completed |
NCT02564341 -
Targeting Effective Analgesia in Clinics for HIV - Intervention
|
N/A | |
| Active, not recruiting |
NCT02302950 -
A Retrospective Analysis of Raltegravir Use in Minority HIV Infected Women in Houston, Texas
|
N/A | |
| Terminated |
NCT01902186 -
Bone Mineral Density Changes in HIV-positive Females With Osteopenia Switching to Raltegravir
|
Phase 4 | |
| Terminated |
NCT02109224 -
Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection
|
Phase 1 | |
| Completed |
NCT02269605 -
Bryostatin-1 Effect on HIV-1 Latency and Reservoir in HIV-1 Infected Patients Receiving Antiretroviral Treatment
|
Phase 1 | |
| Completed |
NCT01852942 -
Reversing Tissue Fibrosis to Improve Immune Reconstitution in HIV
|
Phase 2 | |
| Completed |
NCT01830595 -
Lactoferrin Treatment in HIV Patients
|
Phase 2 | |
| Completed |
NCT01946217 -
Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials
|
N/A | |
| Completed |
NCT02118168 -
Observational Study for the Extended Follow-up of the Patients Enrolled in the Therapeutic Clinical Trial ISS T-002
|
N/A | |
| Completed |
NCT02527135 -
Text Messaging to Improve HIV Testing Among Young Women in Kenya
|
N/A | |
| Completed |
NCT02525146 -
Birmingham Access to Care Study
|
N/A | |
| Active, not recruiting |
NCT02602418 -
Neural Correlates of Working Memory Training for HIV Patients
|
N/A | |
| Completed |
NCT01680094 -
Safety and Effect of The HDAC Inhibitor Panobinostat on HIV-1 Expression in Patients on Suppressive HAART
|
Phase 1/Phase 2 |